Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function

Abstract excerpt

A higher rate of clinical events in poor clopidogrel and/or aspirin responders was documented by using different methods to measure platelet function, but no conclusive data about the appropriate methodology to explore platelet reactivity are available. A total of 746 patients included in the cohort of the RECLOSE trial who had successful drug-eluting stent implantation were assessed for post-treatment residual...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antiplatelet Therapy and Cardiovascular Diseases
• Share to Venous Thromboembolism Diagnosis and Management